Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell TherapyNicolas Gazeau, Jordan Gauthier, Emily C. Liang et al.|Transplantation and Cellular Therapy|2023Cited by 144
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLLEmily C. Liang, Jordan Gauthier, Aya Albittar et al.|Blood Advances|2023Cited by 34
Gut Microbiome Alterations following Postnatal Iron Supplementation Depend on Iron Form and Persist into AdulthoodShasta McMillen, Bo Lönnerdal, Sydney P. Thomas et al.|Nutrients|2022Cited by 16
Development and validation of predictive models of early immune effector cell–associated hematotoxicityEmily C. Liang, Jordan Gauthier, Qian Wu et al.|Blood Advances|2024Cited by 11
Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALLJordan Gauthier, Cameron J. Turtle, Emily C. Liang et al.|Blood Advances|2025Cited by 10